de Leon J, Verghese C, Tracy JI, et al. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry. 1994;35:408-419.
Schrier R. The patient with hyponatremia or hypernatremia. In: Schrier RW, ed. Manual of nephrology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:21-36.
Rose BD, Post TW. Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:748-757,767-772.
1. Verghese C, De Leon J, Josiassen RC. Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophr Bull. 1996;22:455-464.
2. de Leon J. Polydipsia: a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci. 2003;253:37-39.
3. Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry. 1988;145:675-683.
4. Hariprasad MK, Eisinger RP, Nadler IM, et al. Hyponatremia in psychogenic polydipsia. Arch Intern Med. 1980;140:1639-1642.
5. Jose CJ, Barton JL, Perez-Cruet J. Hyponatremic seizures in psychiatric patients. Biol Psychiatry. 1979;14:839-843.
7. Klonoff DC, Jurow AH. Acute water intoxication as a complication of urine drug testing in the workplace. JAMA. 1991;265:84-85.
8. Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am. 2003;32:459-481,vii.
9. Jose CJ, Perez-Cruet J. Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry. 1979;136:221-222.
10. Blum A, Tempey FW, Lynch WJ. Somatic findings in patients with psychogenic polydipsia. J Clin Psychiatry. 1983;44:55-56.
11. de Leon J, Verghese C, Tracy JI, et al. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry. 1994;35:408-419.
12. Gleadhill IC, Smith TA, Yium JJ. Hyponatremia in patients with schizophrenia. South Med J. 1982;75:426-428.
13. Bremner AJ, Regan A. Intoxicated by water: polydipsia and water intoxication in a mental handicap hospital. Br J Psychiatry. 1991;158:244-250.
14. Deb S, Bramble D, Drybala G, et al. Polydipsia amongst adults with a learning disability in an institution. J Intellect Disabil Res. 1994;38:359-367.
15. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med. 1997;102:67-77.
16. Meulendijks D, Mannesse CK, Jansen PA, et al. Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf. 2010;33:101-114.
17. Mannesse CK, van Puijenbroek EP, Jansen PA, et al. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase. Drug Saf. 2010;33:569-578.
18. Kruse D, Pantelis C, Rudd R, et al. Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan). Aust N Z J Psychiatry. 2001;35:65-68.
19. Bralet MC, Ton T, Falissard B. Schizophrenic patients with polydipsia and water intoxication more often have a form of schizophrenia first described by Kraepelin. Psychiatry Res. 2007;152:267-271.
20. Sklar AH, Schrier RW. Central nervous system mediators of vasopressin release. Physiol Rev. 1983;63:1243-1280.
21. Jose CJ, Evenson RC. Antecedents of self-induced water intoxication: a preliminary report. J Nerv Ment Dis. 1980;168:498-500.
22. Blum A. The possible role of tobacco cigarette smoking in hyponatremia of long-term psychiatric patients. JAMA. 1984;252:2864-2865.
23. Thompson CJ, Selby P, Baylis PH. Reproducibility of osmotic and nonosmotic tests of vasopressin secretion in men. Am J Physiol. 1991;260:R533-R539.
24. Gillum DM, Linas SL. Water intoxication in a psychotic patient with normal renal water excretion. Am J Med. 1984;77:773-774.
25. Thompson CJ, Edwards CR, Baylis PH. Osmotic and non-osmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking. Clin Endocrinol (Oxf). 1991;35:221-228.
26. Siegel AJ. Hyponatremia in psychiatric patients: update on evaluation and management. Harv Rev Psychiatry. 2008;16:13-24.
27. Goldman MB. The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness. Brain Res Rev. 2009;61:210-220.
28. Fricchione G, Kelleher S, Ayyala M. Coexisting central diabetes insipidus and psychogenic polydipsia. J Clin Psychiatry. 1987;48:75-76.
29. Goldman MB, Robertson GL, Luchins DJ, et al. The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients. J Clin Endocrinol Metab. 1996;81:1465-1470.
30. Lawson WB, Karson CN, Bigelow LB. Increased urine volume in chronic schizophrenic patients. Psychiatry Res. 1985;14:323-331.
31. Schrier R. The patient with hyponatremia or hypernatremia. In: Schrier RW, ed. Manual of nephrology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:21-36.
32. Douglas I. Hyponatremia: why it matters, how it presents, how we can manage it. Cleve Clin J Med. 2006;73(suppl 3):S4-S12.
33. Tomiyama J, Kametani H, Kumagai Y, et al. Water intoxication and rhabdomyolysis. Jpn J Med. 1990;29:52-55.
34. Wicki J, Rutschmann OT, Burri H, et al. Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia possibly complicated by clozapine. Ann Pharmacother. 1998;32:892-895.
35. Tierney LM Jr, McPhee ST, Papadakis MA. Current medical diagnosis & treatment. 42nd ed. New York, NY: McGraw-Hill; 2002:840-845,1076-1077.
36. Rose BD, Post TW. Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:748-757,767-772.
37. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581-1589.
38. Harrigan MR. Cerebral salt wasting syndrome: a review. Neurosurgery. 1996;38:152-160.
40. Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med. 1981;305:1539-1546.
41. Costanzo ES, Antes LM, Christensen AJ. Behavioral and medical treatment of chronic polydipsia in a patient with schizophrenia and diabetes insipidus. Psychosom Med. 2004;66:283-286.
42. Moses AM, Clayton B. Impairment of osmotically stimulated AVP release in patients with primary polydipsia. Am J Physiol. 1993;265:R1247-R1252.
43. Dashe AM, Cramm RE, Crist CA, et al. A water deprivation test for the differential diagnosis of polyuria. JAMA. 1963;185:699-703.
44. Schrier RW, ed. Atlas of diseases of the kidney. Philadelphia, PA: Current Medicine; 1999.
45. Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999;19:447-452.
46. Twardowschy CA, Bertolucci CB, Gracia Cde M, et al. Severe hyponatremia and syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report. Arq Neuropsiquiatr. 2006;64:142-145.
47. Sachdeo RC, Wasserstein AG, D'Souza J. Oxcarbazepine (Trileptal) effect on serum sodium. Epilepsia. 1999;40(suppl 7):103.
48. Flegel KM, Cole CH. Inappropriate antidiuresis during carbamazepine treatment. Ann Intern Med. 1977;87:722-723.
49. Liamis GL, Milionis HJ, Rizos EC, et al. Mechanisms of hyponatraemia in alcohol patients. Alcohol Alcohol. 2000;35:612-616.
50. Wilkins B. Cerebral oedema after MDMA ("ecstasy") and unrestricted water intake: hyponatraemia must be treated with low water input. BMJ. 1996;313:689-690.
51. Holden R, Jackson MA. Near-fatal hyponatremic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA). Lancet. 1996;347:1052.
52. Rogers G, Elston J, Garside R, et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol Assess. 2009;13:iii-iv,ix-xii,1-315.
53. Thaler SM, Teitelbaum I, Berl T. "Beer potomania" in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis. 1998;31:1028-1031.
54. Han DS, Cho BS. Therapeutic approach to hyponatremia. Nephron. 2002;92(suppl 1):9-13.
55. Offenstadt G, Das V. Hyponatremia, hypernatremia: a physiological approach. Minerva Anestesiol. 2006;72:353-356.
56. Koczapski AB, Millson RC. Individual differences in serum sodium levels in schizophrenic men with self-induced water intoxication. Am J Psychiatry. 1989;146:1614-1615.
57. Vieweg WV, Godleski LS, Graham P, et al. Abnormal diurnal weight gain among long-term patients with schizophrenic disorders. Schizophr Res. 1988;1:67-71.
58. Bowen L, Glynn SM, Marshall BD Jr, et al. Successful behavioral treatment of polydipsia in a schizophrenic patient. J Behav Ther Exp Psychiatry. 1990;21:53-61.
59. Leadbetter RA, Shutty MS Jr. Differential effects of neuroleptic and clozapine on polydipsia and intermittent hyponatremia. J Clin Psychiatry. 1994;55(suppl B):110-113.
60. Lee HS, Kwon KY, Alphs LD, et al. Effect of clozapine on psychogenic polydipsia in chronic schizophrenia. J Clin Psychopharmacol. 1991;11:222-223.
61. Canuso CM, Goldman MB. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome. J Neuropsychiatry Clin Neurosci. 1999;11:86-90.
62. Goldman MB, Hussain N. Absence of effect of olanzapine on primary polydipsia: results of a double-blind, randomized study. J Clin Psychopharmacol. 2004;24:678-680.
63. Rao N, Venkatasubramanian G, Korpade V, et al. Risperidone treatment for polydipsia and hyponatremia in schizophrenia: a case report. Turk Psikiyatri Derg. 2011;22:123-125.
64. Alexander RC, Karp BI, Thompson S, et al. A double blind, placebo-controlled trial of demeclocyline treatment of polydipsia-hyponatremia in chronically psychotic patients. Biol Psychiatry. 1991;30:417-420.
65. White MG, Fetner CD. Treatment of the syndrome of inappropriate secretion of antiduretic hormone with lithium carbonate. N Engl J Med. 1975;292:390-392.
66. Greendyke RM, Bernhardt AJ, Tasbas HE, et al. Polydipsia in chronic psychiatric patients: therapeutic trials of clonidine and enalapril. Neuropsychopharmacology. 1998;18:272-281.
67. Sebastian CS, Bernardin AS. Comparison of enalapril and captopril in the management of self-induced water intoxication. Biol Psychiatry. 1990;27:787-790.
68. Shevitz SA, Jameison RC, Petrie WM, et al. Compulsive water drinking treated with high dose propranolol. J Nerv Ment Dis. 1980;168:246-248.
69. Udelson JE, Smith WB, Hendrix GH, et al. Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation. 2001;104:2417-2423.
70. Josiassen RC, Goldman M, Jessani M, et al. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia. Biol Psychiatry. 2008;64:1097-1100.
71. Takagi S, Watanabe Y, Imaoka T, et al. Treatment of psychogenic polydipsia with acetazolamide: a report of 5 cases. Clin Neuropharmacol. 2011;34:5-7.
72. Hawken ER, Crookall JM, Reddick D, et al. Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: a retrospective study. Schizophr Res. 2009;107:128-133.
73. Delva NJ, Crammer JL, Jarzylo SV, et al. Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia. Biol Psychiatry. 1989;26:781-793.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台